2019 American Transplant Congress
Patient Reported Side Effects Associated with Reduced Quality of Life after Living Donor Kidney Transplant
Northwestern University, Chicago, IL
*Purpose: As living donor kidney transplant (LDKT) graft and patient survival approaches 100%, the focus of care turns to patient reported outcome measures such as…2019 American Transplant Congress
Higher Post-Transplant CXCL13 Correlates with the Occurrence of Infection within 1 Year after Kidney Transplantation
*Purpose: Chemokine is a subtype of cytokines that involved in the process of inflammation and immune responses, and play an important role in both kidney…2019 American Transplant Congress
Pre-Transplant Ventricular Assist Device (VAD) Impacts Heart Transplant (HT) Survival
1Research, LiveOnNY, Manhattan, NY, 2Binghamton University, Binghamton, NY, 3LiveOnNY, Manhattan, NY
*Purpose: Retrospective analysis of UNOS data was performed to determine regional variation in the utilization and impact of VAD prior to HT in the United…2019 American Transplant Congress
Association Between Cumulative Pre-transplant Amiodarone Dose And Post-transplant Outcomes After Heart Transplantation
*Purpose: Previous studies have demonstrated a correlation between pre-transplant amiodarone use and post-operative bradycardia, primary graft dysfunction, and mortality in heart transplant (HT) recipients; this…2019 American Transplant Congress
Infectious Risk of Rejection Therapy Following Heart Transplantation; Can It Be Avoided?
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: The diagnosis of rejection after heart transplantation (HTx) is usually based on the surveillance endomyocardial biopsies (EMB). These protocol biopsies are performed at scheduled…2019 American Transplant Congress
Individualized Preconditioning for ABO-Incompatible Living Donor Kidney Transplantation: An Initial Report of 48 Cases from China
*Purpose: Typically, the majority of centres that perform ABO incompatible (ABOi) kidney transplantation use fixed preconditioning protocols regardless of the initial titer. As experience in…2019 American Transplant Congress
Pushing the Limits: A Large Multicentric Case-Control Study Evaluating the Impact of Kidney Transplants from Expanded Criteria Donors after Controlled Circulatory Death the Limits: A Large Multicentric Case-Control Study Evaluating the Impact of Kidney Transplants from Expanded Criteria Donors after Controlled Circulatory Death
*Purpose: Controlled donation after circulatory death (cDCD) has allowed to significantly increase the deceased donors pool. However, while excellent previous reports have been shown using…2019 American Transplant Congress
Predicting Deceased Donor Kidney Transplant Outcomes: Comparing KDRI/KDPI with Machine Learning
HealthTech Solutions, Inc., Coralville, IA
*Purpose: To better predict outcomes of graft survival in kidney donation and ultimately save more lives for those waiting on the list.*Methods: Machine learning methods…2019 American Transplant Congress
Sequential Dosing of Rituximab and IVIg for Desensitization of Highly-HLA Sensitized (HS) Patients Awaiting HLAi Kidney Transplantation
Kidney Transplant, Cedars Sinai Medical Ctr, Los Angeles, CA
*Purpose: Recent observations suggest that the use of IVIg + rituximab has a critical role in modifying allo-reactive B-cells prior to HLAi kidney transplantation, thus…2019 American Transplant Congress
Safety Outcomes in Elderly Patients Who Receive Alemtuzumab Induction for Kidney Transplant
Ochsner Clinic Foundation, New Orleans, LA
*Purpose: As a consequence of natural immunosenescence, elderly patients may not require as potent immunosuppression as their younger counterparts. Optimal induction regimens in this population,…
- « Previous Page
- 1
- …
- 192
- 193
- 194
- 195
- 196
- …
- 214
- Next Page »